This compound is primarily utilized in research focused on diabetes and metabolic disorders. It acts as an agonist for the GPR40 receptor, which plays a crucial role in enhancing glucose-stimulated insulin secretion. By activating this receptor, it helps in improving insulin release from pancreatic beta cells, making it a potential candidate for developing treatments for type 2 diabetes. Additionally, its mechanism of action is studied to understand its effects on lipid metabolism and its potential to regulate blood sugar levels without causing hypoglycemia. Researchers also explore its therapeutic potential in managing obesity and related metabolic complications.